Hostname: page-component-78c5997874-4rdpn Total loading time: 0 Render date: 2024-11-16T01:16:44.298Z Has data issue: false hasContentIssue false
  • English
  • Français

COVID-19 infection with delayed presentation of infective endocarditis of the prosthetic pulmonary valve

Part of: Interventional Cardiology

Published online by Cambridge University Press:  07 June 2021

Romila Chimoriya Open the ORCID record for Romila Chimoriya [Opens in a new window] ,
Neeraj Awasthy Open the ORCID record for Neeraj Awasthy [Opens in a new window]  and
Gaurav Kumar Open the ORCID record for Gaurav Kumar [Opens in a new window]
Romila Chimoriya
Affiliation:
Department of Pediatric Cardiology, Max Superspeciality Hospital, Saket, New Delhi, India
Neeraj Awasthy*
Affiliation:
Department of Pediatric Cardiology, Max Superspeciality Hospital, Saket, New Delhi, India
Gaurav Kumar
Affiliation:
Department of Pediatric Cardiology, Max Superspeciality Hospital, Saket, New Delhi, India
*
Author for correspondence: Dr N. Awasthy, Department of Pediatric Cardiology, Max Superspeciality Hospital, Saket, A204, Palam Apartments, Sector 5, Plot number 7, Dwarka, New Delhi, India. Tel: +91 9811962775; Fax: +91 1126515050. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Pulmonary valve endocarditis after transcatheter pulmonary valve implantation has been an emerging concern due to the increasing prevalence of transcatheter placement of pulmonary valve in the treatment of residual right ventricular outflow tract stenosis or regurgitation. Pulmonary valve endocarditis is a dreadful complication of transcatheter pulmonary valve implantation that have been reported with Melody valve (Medtronic, Inc., Minneapolis, MN) and Edward Sapien valve (Edwards Life Sciences, Irvine, CA) till date. There are scanty available literatures for pulmonary valve endocarditis with Venus P valve (Venus Medtech, Hangzhou, China) implantation. Furthermore, cardiovascular comorbidity is common in COVID-19 infection with limited evidence of COVID-19 infection concomitant with infective endocarditis. This case happens to be the first reported case of infective endocarditis of pulmonary valve with concomitant COVID-19 infection and also delayed presentation of pulmonary valve endocarditis with Venus P valve implantation.

Keywords

COVID-19infective endocarditispulmonary valve
Type
Brief Report
Information
Cardiology in the Young , Volume 31 , Issue 12 , December 2021 , pp. 2045 - 2047
Check for updates
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Seraj, SM, Gill, E, Sekhon, S. Isolated pulmonary valve endocarditis: truth or myth?. J Community Hosp Intern Med Perspect 2017; 7: 329–331.10.1080/20009666.2017.1374808CrossRefGoogle ScholarPubMed
Bonhoeffer, P, Boudjemline, Y, Saliba, Z, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356: 1403–1405.10.1016/S0140-6736(00)02844-0CrossRefGoogle Scholar
Khambadkone, S, Coats, L, Taylor, A, et al. Percutaneous pulmonary valve implantation in humans: results in 59 consecutive patients. Circulation 2005; 112: 1189–1197.10.1161/CIRCULATIONAHA.104.523266CrossRefGoogle ScholarPubMed
Sadeghi, S, Wadia, S, Lluri, G, et al. Risk factors for infective endocarditis following transcatheter pulmonary valve replacement in patients with congenital heart disease. Catheter Cardiovasc Interv 2019; 94: 625–635.CrossRefGoogle ScholarPubMed
Abdelghani, M, Nassif, M, Blom, NA, et al. Infective endocarditis after melody valve implantation in the pulmonary position: a systematic review. J Am Heart Assoc 2018; 7: e008163.CrossRefGoogle ScholarPubMed
Hascoet, S, Mauri, L, Claude, C, et al. Infective endocarditis risk after percutaneous pulmonary valve implantation with the melody and sapien valves. JACC Cardiovasc Interv 2017; 10: 510–517.10.1016/j.jcin.2016.12.012CrossRefGoogle ScholarPubMed
Mounir, R, Hak Lee, A, Matthew, J, et al. Infolding of the venus P-valve after transcatheter pulmonary valve implantation. Circ Cardiovasc Interv 2018; 11: e005923.Google Scholar
Garay, F, Pan, X, Zhang, YJ, Wang, C, Springmuller, D. Early experience with the venus P-valve for percutaneous pulmonary valve implantation in native outflow tract. Neth Heart J 2017; 25: 76–81.CrossRefGoogle ScholarPubMed
Wang, C, Li, YJ, Ma, L, Pan, X. Infective endocarditis in a patient with transcatheter pulmonary valve implantation. Int Heart J 2019; 60: 983–985.10.1536/ihj.18-497CrossRefGoogle Scholar
Amir, M, Djaharuddin, I, Sudharsono, A, Ramadany, S. COVID-19 concomitant with infective endocarditis: a case report and review of management. Int J Infect Dis 2020; 98: 109–112.CrossRefGoogle ScholarPubMed

Chimoriya et al. supplementary material

Chimoriya et al. supplementary material

Download Chimoriya et al. supplementary material(Audio)
Audio 13.6 MB